Adherence to Anti Retroviral Therapy (ART) During Muslim Ramadan Fasting

被引：18

作者：

Habib, A. G. ^{[1
,2
,3
]}

Shepherd, J. C. ^{[4
]}

Eng, M. K. L. ^{[4
]}

Babashani, M. ^{[2
,3
]}

Jumare, J. ^{[1
]}

Yakubu, U. ^{[1
,2
]}

Gebi, U. I. ^{[1
]}

Saad, M. ^{[1
]}

Ibrahim, H. ^{[1
]}

Blattner, W. A. ^{[4
]}

机构：

[1] Inst Human Virol, Garki, Abuja, Nigeria

[2] Aminu Kano Teaching Hosp, Kano, Nigeria

[3] Bayero Univ Kano, Kano, Nigeria

[4] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA

来源：

AIDS AND BEHAVIOR | 2009年 / 13卷 / 01期

关键词：

Adherence; Antiretroviral therapy; Fasting; HIV; Islam; HIV-1-INFECTED PATIENTS; PHARMACOKINETICS; AFRICA; HIV;

D O I：

10.1007/s10461-008-9412-2

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Annual fasting during the month of Ramadan is observed in Muslim countries, some of which have widespread HIV infection. We studied treatment adherence and customary practices among 142 fasting 'FT' and 101 non-fasting 'NFT' patients on anti-retroviral therapy (ART) in Nigeria. Adherence on ART among FT and NFT patients was similar during Ramadan, 96% and 98%, and ever since commencement of ART, 80% and 88%, respectively. FT patients altered their typical daily behaviors by advancing morning and delaying evening doses thereby prolonging dosing intervals, eating heavier meals pre-dawn and on breakfast at sunset (78%), and changing or reducing their sleeping and waking times (40%). This preliminary study suggests that adherence and drug taking frequency appear uncompromised in FT HIV infected patients on ARVs.

引用

页码：42 / 45

页数：4

共 11 条

[1] Drug intake during ramadan
Aadil, N
Houti, IE
Moussamih, S
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7469): : 778 - 782B
[2] Diabetes and Ramadan: Review of the literature
Benaji, B.
Mounib, N.
Roky, R.
Aadil, N.
Houti, I. E.
Moussamih, S.
Maliki, S.
Gressier, B.
El Ghomari, H.
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 73 (02) : 117 - 125
[3] Burger DM, 1998, ANTIVIR THER, V3, P215
[4] Crane JR, 2000, AIDS EDUC PREV, V12, P532
[5] Initial therapy of HIV infection
Gallant, JE
[J]. JOURNAL OF CLINICAL VIROLOGY, 2002, 25 (03) : 317 - 333
[6] Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects
Hsu, A
Granneman, GR
Witt, G
Locke, C
Denissen, J
Molla, A
Valdes, J
Smith, J
Erdman, K
Lyons, N
Niu, P
Decourt, JP
Fourtillan, JB
Girault, J
Leonard, JM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 898 - 905
[7] Diurnal variation of plasma protease inhibitor concentrations
Justesen, US
Pedersen, C
[J]. AIDS, 2002, 16 (18) : 2487 - 2489
[8] PEPFAR and HIV prevention in Africa
Kamwi, Richard
Kenyon, Thomas
Newton, Gary
[J]. LANCET, 2006, 367 (9527) : 1978 - 1979
[9] Piot P, 2001, B WORLD HEALTH ORGAN, V79, P1106
[10] Antiretroviral therapy in Africa
Stevens, W
Kaye, S
Corrah, T
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7434): : 280 - 282

← 1 2 →